The Pharmacokinetic Study of the Combination of Digoxin and Polythylene Glycol Loxenatide Injection in Healthy Subjects
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetic study of the combination of
digoxin and polythylene glycol loxenatide injection (PEX168) in healthy adults，and to provide
scientific basis for clinical combination of PEX168 and drugs.This study is also to evaluate
the safety and tolerability of mono-digoxin or digoxin plus PEX168.
Phase:
Phase 1
Details
Lead Sponsor:
First Affiliated Hospital Xi'an Jiaotong University